Peptides for Cachexia Treatment
Reviewed by Marcus Hopkin, PhD
Director of Research and Development, Volta Peptides
Written by Volta Peptides Editorial Team · Reviewed September 15, 2026
This guide provides an in-depth analysis of two peptides currently under investigation for the treatment of cachexia, a complex syndrome characterized by weight loss and muscle wasting often associated with chronic illnesses. The peptides are ranked based on the strength of available evidence, from those with regulatory approval to those in early preclinical stages. Each compound is examined with respect to its mechanism of action, clinical status, and safety profile, providing a comprehensive resource for researchers exploring therapeutic options for cachexia.
Overview
2 research peptides are currently studied for cachexia treatment. This guide ranks them by evidence strength and covers their mechanisms, safety profiles, and current clinical status.
Anamorelin — Phase III / Regulatory Approval (Japan)
Anamorelin is a synthetic, orally bioavailable agonist of the ghrelin receptor (GHS-R1a) specifically developed to address cancer-related cachexia. Its design allows for once-daily administration, ensuring sustained receptor activation, which is a notable advantage over endogenous ghrelin, which is rapidly metabolized. In 2021, anamorelin received regulatory approval in Japan for use in patients suffering from cachexia associated with non-small cell lung cancer (NSCLC), gastric, pancreatic, and colorectal cancers. This approval marks it as one of the few peptide therapeutics explicitly indicated for cachexia. Clinical trials have demonstrated that anamorelin can significantly increase lean body mass and stimulate appetite in affected cancer patients, contributing to improved nutritional status. However, it is important to note that as of now, anamorelin has not received approval from the FDA or EMA, which limits its availability in other markets.
Ghrelin — Well-characterized endogenous hormone with approved analogs
Ghrelin, a 28-amino acid peptide hormone primarily secreted by the stomach, functions as the endogenous ligand for the growth hormone secretagogue receptor (GHS-R1a). It is distinguished as the only known circulating orexigenic hormone, playing a crucial role in stimulating appetite and promoting growth hormone release. Ghrelin's biological activity is contingent upon a specific post-translational modification known as n-octanoylation at the serine 3 position. Beyond its appetite-stimulating effects, ghrelin also influences energy metabolism and fat storage, thereby playing a multifaceted role in metabolic regulation. Research indicates that pharmaceutical analogs of ghrelin, including anamorelin, have been developed to harness its appetite-enhancing properties for treating conditions such as cancer-related cachexia. While ghrelin itself is not approved as a therapeutic agent, its analogs represent a promising avenue for addressing cachexia, particularly in cancer patients.
Shop Research Peptides
Cagrilintide 5mg
DSIP 10mg
Epithalon 10mg
GHRP-2 5mg
5mg
Quality Documentation
Review batch documentation before making research purchasing decisions. Volta pairs product education with COA literacy so researchers can evaluate purity, identity, lot details, and testing context.
Product cards on this page link to current catalog entries and available quality documentation.
Related Research News
CJC-1295 with DAC and Ipamorelin: Growth Hormone Research Guide
CJC-1295 with DAC and Ipamorelin represent key compounds in growth hormone research, targeting distinct pathways for GH and IGF-1 signaling. CJC-1295 with DAC acts as a long-acting GHRH analogue with a half-life of 5.8 to 8.1 days, while Ipamorelin functions as a selective growth hormone secretagogue via the ghrelin receptor. Together, they support studies on metabolism, recovery, and body composition.
Ipamorelin vs GHRP-2: Which Offers More Targeted GH Release?
Ipamorelin and GHRP-2 both stimulate growth hormone release via the ghrelin receptor, but Ipamorelin provides more selective action with minimal impact on other hormones like ACTH and cortisol. GHRP-2 delivers stronger GH pulses alongside broader endocrine effects. Combining them can enhance overall GH output through additive receptor stimulation.
Peptide Tools
Key research references
- Best Peptides for Anti-Aging | Research Guide
- Best Peptides for Metabolic Health | Research Guide
- Best Peptides for Weight Management | Research Guide
- Best Peptides for Body Composition | Research Guide
- Best Peptides for Reproductive Health | Research Guide
- Best Peptides for Anti-Aging & Longevity | Research Guide
- Best Peptides for Weight Loss | Research Guide
- Best Peptides for Cognitive Enhancement | Research Guide
- Retatrutide Dosing Guide | Protocols & Reconstitution
- Wound Healing Peptides | Research Compounds
- Muscle Growth Peptides | Research Compounds
- Immune Modulation Peptides | Research Compounds
Browse the research catalogue
Buying and verification
Frequently Asked Questions
Related Resources
Related Research
About the reviewer
Director of Research and Development, Volta Peptides
Marcus Hopkin, PhD, is Director of Research and Development at Volta Peptides. He has more than 12 years of analytical chemistry experience, including direct laboratory work in peptide synthesis, characterization, purity testing and stability assessment. His doctoral research at the University of Michigan examined novel peptide structures in the human proteome and their potential significance for therapeutic-peptide research. Before joining Volta Peptides he held research and development roles at Amgen and Eli Lilly and Company, and served as a lecturer at the University of Michigan.
Marcus reviewed this article for scientific and analytical accuracy on September 15, 2026. He did not write it. Technical review is internal review and is not peer review, independent third-party review or medical review.
Disclosure. Marcus Hopkin is an employee of Volta Peptides and serves as its Director of Research and Development. Volta Peptides sells research compounds related to subjects discussed in the content he writes and reviews. His reviews are internal scientific and technical review and must not be described as independent third-party review, peer review or medical review.